Skip to main content
Top
Published in: Virology Journal 1/2019

Open Access 01-12-2019 | Human Papillomavirus | Research

Characteristics of human papillomaviruses distribution in Guizhou Province, China

Authors: Zuyi Chen, Qiongyao Li, Qiong Huang, Huaqing Liu, Hongwu Jiang, Zehui Chen, Zhengyuan An, Qingfang Luo

Published in: Virology Journal | Issue 1/2019

Login to get access

Abstract

Background

Human papillomavirus (HPV) is one of the most common sexually transmitted viruses. Data about HPV infection in Guizhou is limited.

Methods

56,768 cervical samples were collected and genotyped for 15 main high risk and 6 main low risk HPV types.

Results

16.95% (9623/56768) of samples were HPV positive; 90.70% (8728/9623) of HPV positive women were infected by high risk HPV. High risk and high risk mix infection (1458; 70.85%) was the most common mix HPV infection type. The highest HPV detection rate was found in age group 41–45 years old (detection rate = 17.89%) (χ2 = 204.77; P < 0.001); the highest within-group HPV infection rates were found in the ≤20 (25.62%) and ≥ 61 (24.67%) years old age groups, the lowest within-group HPV infection rate was found in the 31–35 years old age group (15.02%). The highest mix infection proportions were found in the ≥61 (36.06%) and ≤ 20 (33.63%) years old age groups (χ2 = 111.21; P < 0.001), the lowest mix infection proportion was found in the 41–45 (17.42%) years old age group. The highest high risk infection proportions were found in the 26–30 (92.98%), ≥61 (92.68%), and 36–40 (92.16%) years old age groups (χ2 = 31.72; P < 0.001), the lowest high risk infection proportion was found in the ≤20 (84.96%) years old age group. HPV infection rates varied with seasons in Guizhou.

Conclusions

Characteristics of HPV distribution in Guizhou were identified. There were significant differences in HPV distribution among age groups, prevention strategies should be adjusted according to the characteristics.
Literature
1.
go back to reference Martins TR, de Oliveira CM, Rosa LR, et al. HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data[J]. Virol J. 2016;13(1):138.CrossRef Martins TR, de Oliveira CM, Rosa LR, et al. HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data[J]. Virol J. 2016;13(1):138.CrossRef
2.
go back to reference Chen Z, Jing Y, Wen Q, et al. E6 and E7 gene polymorphisms in human papillomavirus types-58 and 33 identified in Southwest China[J]. PLoS One. 2017;12(1):e0171140.CrossRef Chen Z, Jing Y, Wen Q, et al. E6 and E7 gene polymorphisms in human papillomavirus types-58 and 33 identified in Southwest China[J]. PLoS One. 2017;12(1):e0171140.CrossRef
3.
go back to reference Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts[J]. Dermatology online journal. 2006;12(3):5–5.PubMed Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts[J]. Dermatology online journal. 2006;12(3):5–5.PubMed
4.
go back to reference Muñoz N, Bosch FX, De Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med. 2003;348(6):518–27.CrossRef Muñoz N, Bosch FX, De Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med. 2003;348(6):518–27.CrossRef
5.
go back to reference Chen Z, Jing Y, Wen Q, et al. L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis[J]. Virol J. 2016;13(1):167.CrossRef Chen Z, Jing Y, Wen Q, et al. L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis[J]. Virol J. 2016;13(1):167.CrossRef
6.
go back to reference Castellsague X. HPV and cervical Cancer in the world: 2007 report (section I continents and regions)[J]. Vaccine. 2007;25:C1–C26.CrossRef Castellsague X. HPV and cervical Cancer in the world: 2007 report (section I continents and regions)[J]. Vaccine. 2007;25:C1–C26.CrossRef
7.
go back to reference Ursu RG, Onofriescu M, Nemescu D, et al. HPV prevalence and type distribution in women with or without cervical lesions in the northeast region of Romania[J]. Virol J. 2011;8(1):558.CrossRef Ursu RG, Onofriescu M, Nemescu D, et al. HPV prevalence and type distribution in women with or without cervical lesions in the northeast region of Romania[J]. Virol J. 2011;8(1):558.CrossRef
8.
go back to reference Chen Z, Wang Q, Ding X, et al. Characteristics of HPV prevalence in Sichuan Province, China[J]. Int J Gynecol Obstet. 2015;131(3):277–80.CrossRef Chen Z, Wang Q, Ding X, et al. Characteristics of HPV prevalence in Sichuan Province, China[J]. Int J Gynecol Obstet. 2015;131(3):277–80.CrossRef
9.
go back to reference Zeng Z, Yang H, Li Z, et al. Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China's largest CAP certified laboratory[J]. J Cancer. 2016;7(9):1037.CrossRef Zeng Z, Yang H, Li Z, et al. Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China's largest CAP certified laboratory[J]. J Cancer. 2016;7(9):1037.CrossRef
10.
go back to reference Zhao P, Liu S, Zhong Z, et al. Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China[J]. BMC Infect Dis. 2018;18(1):204.CrossRef Zhao P, Liu S, Zhong Z, et al. Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China[J]. BMC Infect Dis. 2018;18(1):204.CrossRef
11.
go back to reference Zhao R, Zhang WY, Wu MH, et al. Human papillomavirus infection in Beijing, People's Republic of China: a population-based study[J]. Br J Cancer. 2009;101(9):1635.CrossRef Zhao R, Zhang WY, Wu MH, et al. Human papillomavirus infection in Beijing, People's Republic of China: a population-based study[J]. Br J Cancer. 2009;101(9):1635.CrossRef
12.
go back to reference Chen X, Wallin KL, Duan M, et al. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China[J]. J Med Virol. 2015;87(11):1966–72.CrossRef Chen X, Wallin KL, Duan M, et al. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China[J]. J Med Virol. 2015;87(11):1966–72.CrossRef
13.
go back to reference Wang S, Wei H, Wang N, et al. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China[J]. BMC Cancer. 2012;12(1):160.CrossRef Wang S, Wei H, Wang N, et al. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China[J]. BMC Cancer. 2012;12(1):160.CrossRef
14.
go back to reference Chen Q, Luo ZY, Lin M, et al. Prevalence and genotype distribution of human papillomavirus infections in women attending hospitals in Chaozhou of Guangdong province[J]. Asian Pac J Cancer Prev. 2012;13(4):1519–24.CrossRef Chen Q, Luo ZY, Lin M, et al. Prevalence and genotype distribution of human papillomavirus infections in women attending hospitals in Chaozhou of Guangdong province[J]. Asian Pac J Cancer Prev. 2012;13(4):1519–24.CrossRef
15.
go back to reference Baboci L, Boscolo-Rizzo P, Holzinger D, et al. Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma[J]. Virol J. 2013;10(1):334.CrossRef Baboci L, Boscolo-Rizzo P, Holzinger D, et al. Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma[J]. Virol J. 2013;10(1):334.CrossRef
16.
go back to reference Anderson LA, O'Rorke MA, Wilson R, et al. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: a population-based study from Northern Ireland[J]. J Med Virol. 2016;88(7):1262–70.CrossRef Anderson LA, O'Rorke MA, Wilson R, et al. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: a population-based study from Northern Ireland[J]. J Med Virol. 2016;88(7):1262–70.CrossRef
17.
go back to reference Hibbitts S, Rieck GC, Hart K, et al. Human papillomavirus infection: an anonymous prevalence study in South Wales, UK[J]. Br J Cancer. 2006;95(2):226–32.CrossRef Hibbitts S, Rieck GC, Hart K, et al. Human papillomavirus infection: an anonymous prevalence study in South Wales, UK[J]. Br J Cancer. 2006;95(2):226–32.CrossRef
18.
go back to reference Karanam B, Jagu S, Huh WK, et al. Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection[J]. Immunol Cell Biol. 2009;87(4):287–99.CrossRef Karanam B, Jagu S, Huh WK, et al. Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection[J]. Immunol Cell Biol. 2009;87(4):287–99.CrossRef
Metadata
Title
Characteristics of human papillomaviruses distribution in Guizhou Province, China
Authors
Zuyi Chen
Qiongyao Li
Qiong Huang
Huaqing Liu
Hongwu Jiang
Zehui Chen
Zhengyuan An
Qingfang Luo
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2019
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-019-1239-0

Other articles of this Issue 1/2019

Virology Journal 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.